Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia

Transfusion and Apheresis Science

Volumn 46, Issue 2, 2012, Pages 159-162

  Theodoulou, A ^a   Berryman, J ^a   Nathwani, A ^a,b   Scully, M ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acquired hypofibrinogenaemia; Cryoprecipitate; Fibrinogen concentrate

Indexed keywords

FIBRINOGEN;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOPRECIPITATE; HUMAN; HYPOFIBRINOGENEMIA; RETROSPECTIVE STUDY;

AFIBRINOGENEMIA; FACTOR VIII; FEMALE; FIBRINOGEN; GREAT BRITAIN; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 84858278490     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2011.11.005     Document Type: Article

References (12)

1. Danes A.F., Cuenca L.G., Bueno S.R., Mendarte B.L., Ronsano J.B. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang 2008, 94(3):221-226.
2. Kreuz W., Meili E., Peter-Salonen K., Haertel S., Devay J., Krzensk U., et al. Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfus Apher Sci 2005, 32(3):247-253.
3. Weinkove R., Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 2008, 18(3):151-157.
4. Manco-Johnson M.J., Dimichele D., Castaman G., Fremann S., Knaub S., Kalina U., et al. Pharmacokinetics and safety of fibrinogen concentrate. J Thromb Haemost 2009, 7(12):2064-2069.
5. Sorensen B., Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010, 149(6):834-843.
6. Tziomalos K., Vakalopoulou S., Perifanis V., Garipidou V. Treatment of congenital fibrinogen deficiency: overview and recent findings. Vasc Health Risk Manag 2009, 5:843-848.
7. O'Shaughnessy D.F., Atterbury C., Bolton M.P., Murphy M., Thomas D., Yates S., et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004, 126(1):11-28.
8. Bolton-Maggs P.H., Perry D.J., Chalmers E.A., Parapia L.A., Wilde J.T., Williams M.D., et al. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004, 10(5):593-628.
9. Kreuz W., Meili E., Peter-Salonen K., Dobrkovska A., Devay J., Haertel S., et al. Pharmacokinetic properties of a pasteurised fibrinogen concentrate. Transfus. Apher. Sci. 2005, 32(3):239-246.
10. Fenger-Eriksen C., Lindberg-Larsen M., Christensen A.Q., Ingerslev J., Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008, 101(6):769-773.
11. Rahe-Meyer N., Pichlmaier M., Haverich A., Solomon C., Winterhalter M., Piepenbrock S., et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009, 102(6):785-792.
12. Solomon C., Pichlmaier U., Schoechl H., Hagl C., Raymondos K., Scheinichen D., et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010, 104(5):555-562.